OncoSec Medical, Inc. (ONCSQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Sep 10, 16:00
OncoSec Medical Gross Profit (TTM)
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| January 31, 2023 | -0.9874M |
| October 31, 2022 | -1.221M |
| July 31, 2022 | -1.066M |
| April 30, 2022 | -1.038M |
| January 31, 2022 | -1.008M |
| October 31, 2021 | -0.9777M |
| July 31, 2021 | -1.078M |
| April 30, 2021 | -1.058M |
| January 31, 2021 | -1.043M |
| October 31, 2020 | -1.024M |
| July 31, 2020 | -0.9908M |
| April 30, 2020 | -0.7916M |
| January 31, 2020 | -0.5944M |
| October 31, 2019 | -0.408M |
| July 31, 2019 | -0.2433M |
| April 30, 2019 | -0.2444M |
| January 31, 2019 | -0.2834M |
| October 31, 2018 | -0.3174M |
| July 31, 2018 | -0.3524M |
| April 30, 2018 | -0.3867M |
| January 31, 2018 | -0.382M |
| October 31, 2017 | -0.3812M |
| July 31, 2017 | -0.38M |
| April 30, 2017 | -0.3862M |
| January 31, 2017 | -0.345M |
| Date | Value |
|---|---|
| October 31, 2016 | -0.3372M |
| July 31, 2016 | -0.3075M |
| April 30, 2016 | -0.2684M |
| January 31, 2016 | -0.3845M |
| October 31, 2015 | -0.5184M |
| July 31, 2015 | -0.6646M |
| April 30, 2015 | -0.8023M |
| January 31, 2015 | -0.8294M |
| October 31, 2014 | -0.801M |
| July 31, 2014 | -0.7801M |
| April 30, 2014 | -0.7655M |
| January 31, 2014 | -0.7523M |
| October 31, 2013 | -0.7438M |
| July 31, 2013 | -0.7369M |
| April 30, 2013 | -0.5509M |
| January 31, 2013 | -0.367M |
| October 31, 2012 | -0.366M |
| July 31, 2012 | -0.3502M |
| April 30, 2012 | -0.5353M |
| January 31, 2012 | -0.5979M |
| October 31, 2011 | -0.4154M |
| July 31, 2011 | -0.2478M |
| April 30, 2011 | -0.0626M |
| January 31, 2011 | 0.00 |
| October 31, 2010 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Alnylam Pharmaceuticals, Inc. | 3.827B |
| Anika Therapeutics, Inc. | 75.00M |
| Savara, Inc. | -0.281M |
| Vericel Corp. | 228.38M |